• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Mohs better suited to remove sebaceous carcinoma of eyelid

Article

New York - With postexcision recurrence rates of 30 percent , Mohs surgery might be the better alternative in the treatment of sebaceous gland carcinoma, according to James M. Spencer, M.D.)

Recent Videos
Related Content
Phase 3 LIBERTY-CUPID Study C Trial for Dupilumab Meets Primary, Secondary Endpoints for Chronic Spontaneous Urticaria

Phase 3 LIBERTY-CUPID Study C Trial for Dupilumab Meets Primary, Secondary Endpoints for Chronic Spontaneous Urticaria

Article
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

Podcast
Research Observe, Classify Adverse Event Profiles for Pediatric Patients Treated With JAK Inhibitors

Research Observe, Classify Adverse Event Profiles for Pediatric Patients Treated With JAK Inhibitors

Article
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Podcast
CG and Minoxidil Combination Therapy Shows Promise for AA

CG and Minoxidil Combination Therapy Shows Promise for AA

Article
Preclinical Medical Students Perform Similarly in Evaluating, Diagnosing Dermatological Diseases in Varying Skin Types

Preclinical Medical Students Perform Similarly in Evaluating, Diagnosing Dermatological Diseases in Varying Skin Types

Article
© 2024 MJH Life Sciences

All rights reserved.